The need for randomized controlled trials in podiatric medical research

Journal of the American Podiatric Medical Association

Volumn 94, Issue 3, 2004, Pages 221-228

  Porthouse, Jill ^a   Torgerson, David J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CICLOPIROX; DEXAMETHASONE SODIUM PHOSPHATE; IBUPROFEN; PARACETAMOL; PARAFFIN; POVIDONE IODINE; SILICONE DERIVATIVE;

ANESTHESIA INDUCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA BASE; DIABETIC FOOT; DRUG EFFICACY; EVALUATION; FOLLOW UP; FOOT ULCER; HEALTH CARE; HEALTH PROGRAM; HUMAN; HYDROGEL; INFECTION; INJECTION PAIN; LOW LEVEL LASER THERAPY; MEDICAL RESEARCH; METHODOLOGY; ONYCHOMYCOSIS; OSTEOLYSIS; PODIATRY; QUALITATIVE ANALYSIS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SCREENING TEST; SURGICAL WOUND; TREATMENT OUTCOME; WOUND DRESSING; WOUND HEALING;

EID: 2642539071     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/0940221     Document Type: Article

References (31)

1. MEDICAL RESEARCH COUNCIL: Streptomycin treatment of pulmonary tuberculosis: a report of the Streptomycin in Tuberculosis Trials Committee. BMJ 2: 769, 1948.
2. SACKETT DL, HOEY J: Why randomized controlled trials fail but needn't: a new series is launched. CMAJ 162: 1301, 2000.
3. FREIMAN JA, CHALMERS TC, SMITH H JR, ET AL: The importance of beta, the type II error and sample size in the design and interpretation of the randomized controlled trial: a survey of 71 "negative" trials. N Engl J Med 299: 690, 1978.
4. MOHER D, DULBERG CS, WELLS GA: Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 272: 122, 1994.
5. BEGG CB, CHO MK, EASTWOOD S, ET AL: Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 276: 637, 1996.
6. CONSORT Statement. Available at: http://www.consort-statement.org. Accessed August 29, 2002.
7. LANDORF KB: Ensuring adequate reporting of randomized controlled trials: the CONSORT statement [commentary]. JAPMA 91: 435, 2001.
8. JOSEPH WS: Introduction to Landorf KB: Ensuring adequate reporting of randomized controlled trials: the CONSORT statement [commentary]. JAPMA 91: 435, 2001.
9. TURLIK MA, KUSHNER D: Levels of evidence in articles in podiatric medical journals. JAPMA 90: 300, 2000.
10. CRAWFORD F, ATKINS D, EDWARDS J: Interventions for treating plantar heel pain. Cochrane Database Syst Rev 3: CD000416, 2000.
11. BELL-SYER SE, HART R, CRAWFORD F, ET AL: A systematic review of oral treatments for fungal infections of the skin of the feet. J Dermatolog Treat 12: 69, 2001.
12. FERRARI J, HIGGINS JPT, WILLIAMS RL: Interventions for treating hallux valgus (abductovalgus) and bunions. Cochrane Database Syst Rev 2: CD000964, 2000.
13. GIBBS S, HARVEY I, STERLING JC, ET AL: Local treatments for cutaneous warts. BMJ 325: 461, 2002.
14. BRYANT A, MAHONEY B, TINLEY P: Lateral intermetatarsal angle: a useful measurement of metatarsus primus elevatus? JAPMA 91: 251, 2001.
15. GUPTA AK, JOSEPH WS: Ciclopirox 8% nail lacquer in the treatment of onychomycosis of the toenails in the United States. JAPMA 90: 495, 2000.
16. HEAD J, BRYANT B, EBELING P: Short term use of ibuprofen or paracetamol affects bone resorption in healthy males: a double blind, placebo controlled study. Australas J Podiatric Med 32 (suppl): 1, 1998.
17. MCCABE CJ, STEVENSON RC, DOLAN AM: Evaluation of a diabetic foot screening and protection programme. Diabet Med 15: 80, 1998.
18. MILLER SL, WERTHEIMER SJ: A comparison of the efficacy of injectable dexamethasone sodium phosphate versus placebo in postoperative podiatric analgesia. J Foot Ankle Surg 37: 223, 1998.
19. PIETTE JD, WEINBERGER M, KRAEMER FB, ET AL: Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System: a randomized controlled trial. Diabetes Care 24: 202, 2001.
20. PLOTKIN S: Clinical comparison of preinjection anesthetics. JAPMA 88: 73, 1998.
21. RONNEMAA T, HAMALAINEN H, TOIKKA T, ET AL: Evaluation of the impact of podiatrist care in the primary prevention of foot problems in diabetic subjects. Diabetes Care 20: 1833, 1997.
22. VAN SCHIE CH, WHALLEY A, VILEIKYTE L, ET AL: Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial. Diabetes Care 23: 634, 2000.
23. DOVISON R, KEENAN AM: Wound healing and infection in nail matrix phenolization wounds: does topical medication make a difference? JAPMA 91: 230, 2001.
24. HAMALAINEN H, RONNEMAA T, TOIKKA T, ET AL: Long-term effects of one year of intensified podiatric activities on foot care knowledge and self-care habits in patients with diabetes. Diabetes Educ 24: 734, 1998.
25. LAGAN KM, CLEMENTS BA, MCDONOUGH S, ET AL: Low intensity laser therapy (830nm) in the management of minor postsurgical wounds: a controlled clinical study. Lasers Surg Med 28: 27, 2001.
26. THOMSON CE, MORROW LJ, MARTIN DJ: A randomised double blind trial to compare pain on digital injection of warm and cold anaesthetic. The Foot 8: 89, 1998.
27. VAN GILS CC, ROEDER B, CHESLER SM, ET AL: Improved healing with a collagen-alginate dressing in the chemical matricectomy. JAPMA 88: 452, 1998.
28. SCHULZ KF, CHALMERS I, GRIMES DA, ET AL: Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA 272: 125, 1994.
29. SCHULZ KF: Subverting randomization in controlled trials. JAMA 274: 1456, 1995.
30. KENNEDY A, GRANT A: Subversion of allocation in a randomised controlled trial. Control Clin Trials 18: 35, 1997.
31. SILVERMAN W: "Risks and Benefits of Medical Innovations," in Non-Random Reflections on Health Services Research, ed by A Maynard, I Chalmers, BMJ Publications, London, 1997.